Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors
For Financial Professionals in the US

Global Life Sciences Fund Holdings

Full Portfolio Holdings

(As of 09/30/2024)

% OF INVESTMENTS
Eli Lilly & Co 8.45
UnitedHealth Group Inc 6.85
Novo Nordisk A/S 4.65
AstraZeneca PLC 3.65
AbbVie Inc 3.61
Amgen Inc 3.24
Sanofi SA 2.78
Merck & Co Inc 2.57
Boston Scientific Corp 2.51
Johnson & Johnson 2.48
Abbott Laboratories 2.38
Novartis AG (ADR) 2.26
Vertex Pharmaceuticals Inc 2.24
Thermo Fisher Scientific Inc 1.98
Argenx SE (ADR) 1.95
Vaxcyte Inc 1.89
Danaher Corp 1.86
Stryker Corp 1.85
Intuitive Surgical Inc 1.68
Sarepta Therapeutics Inc 1.50
HCA Healthcare Inc 1.45
Elevance Health Inc 1.44
Ascendis Pharma A/S (ADR) 1.29
Roche Holding AG 1.24
Globus Medical Inc 1.13
Biohaven Ltd 1.03
Akero Therapeutics Inc 1.01
United Therapeutics Corp 0.97
Madrigal Pharmaceuticals Inc 0.94
REVOLUTION Medicines Inc 0.93
Dyne Therapeutics Inc 0.89
Humana Inc 0.82
Zoetis Inc 0.82
Teleflex Inc 0.81
McKesson Corp 0.78
Lantheus Holdings Inc 0.78
Medtronic PLC 0.76
Avidity Biosciences Inc 0.75
Cooper Cos Inc 0.73
Arcellx Inc 0.71
Penumbra Inc 0.69
Cencora Inc 0.68
Teva Pharmaceutical Industries Ltd (ADR) 0.66
Regeneron Pharmaceuticals Inc 0.63
Inspire Medical Systems Inc 0.61
Avadel Pharmaceuticals PLC 0.61
STERIS PLC 0.59
Edwards Lifesciences Corp 0.59
Zai Lab Ltd (ADR) 0.59
Structure Therapeutics Inc (ADR) 0.57
Soleno Therapeutics Inc 0.56
Mirum Pharmaceuticals Inc 0.56
Ardelyx Inc 0.55
Illumina Inc 0.51
Ideaya Biosciences Inc 0.47
Centene Corp 0.47
Legend Biotech Corp (ADR) 0.43
Sotera Health Co 0.41
ICON PLC 0.40
Hoya Corp 0.40
Alnylam Pharmaceuticals Inc 0.40
89bio Inc 0.38
Gilead Sciences Inc 0.38
Royalty Pharma plc 0.37
Cytokinetics Inc 0.34
Janux Therapeutics Inc 0.34
Crinetics Pharmaceuticals Inc 0.34
PTC Therapeutics Inc 0.32
Amicus Therapeutics Inc 0.30
Align Technology Inc 0.30
Neurocrine Biosciences Inc 0.30
Takeda Pharmaceutical Co Ltd 0.28
Insmed Inc 0.28
Edgewise Therapeutics Inc 0.27
NeoGenomics Inc 0.27
DexCom Inc 0.26
Rhythm Pharmaceuticals Inc 0.26
IQVIA Holdings Inc 0.23
Bridgebio Pharma Inc 0.23
Xenon Pharmaceuticals Inc 0.22
Perspective Therapeutics Inc 0.22
Immunome Inc 0.20
Neurogene Inc 0.20
CG oncology Inc 0.20
Bicara Therapeutics Inc 0.19
4D Molecular Therapeutics Inc 0.19
Geron Corp 0.19
Cargo Therapeutics Inc 0.18
Rocket Pharmaceuticals Inc 0.17
Bridgebio Pharma Inc 0.16
Lexeo Therapeutics Inc 0.12
Heartflow Inc 0.11
Curevo Inc 0.10
Shoreline Biosciences Inc 0.10
Bicara Therapeutics Inc 0.09
Attralus Inc 0.09
Sonoma Biotherapeutics Inc 0.08
Element Biosciences Inc 0.07
Magnolia Medical Technologies Inc 0.05
Asher Biotherapeutics Inc 0.05
Sonoma Biotherapeutics Inc 0.04
Freenome Holdings Inc 0.03
Freenome Holdings Inc 0.03
Asher Biotherapeutics Inc 0.02
Twinstrand Biosciences Inc 0.02
Green Cross Holdings Corp 0.02
Arbor Biotechnologies Inc 0.01
Magnolia Medical Technologies Inc, 10.00%, 12/31/25 0.01
Magnolia Medical Technologies 0.00
Clementia Pharmaceuticals Inc 0.00
Cash & Equivalents 0.35
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.